Clinical trial
QT on RIBociclib measuRed by ArTificial INteliGence
NCT05623397 is registered in ClinicalTrials.gov with CMC Ambroise Paré as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- QT on RIBociclib measuRed by ArTificial INteliGence
- Lead sponsor
- CMC Ambroise Paré
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 28, 2023
- Completion date
- October 8, 2025
- Enrollment
- 70 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, ribociclib